Great Lakes Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Sell |
64,803
-2,033
| -3% | -$133K | 0.04% | 319 |
|
|
2025
Q1 | $4.47M | Sell |
66,836
-7,391
| -10% | -$495K | 0.04% | 295 |
|
|
2024
Q4 | $4.1M | Buy |
74,227
+3,591
| +5% | +$199K | 0.04% | 367 |
|
|
2024
Q3 | $4.21M | Buy |
70,636
+14,555
| +26% | +$868K | 0.04% | 377 |
|
|
2024
Q2 | $3.57M | Buy |
56,081
+5,359
| +11% | +$341K | 0.03% | 385 |
|
|
2024
Q1 | $3.51M | Buy |
50,722
+2,470
| +5% | +$171K | 0.03% | 399 |
|
|
2023
Q4 | $2.66M | Buy |
48,252
+19,378
| +67% | +$1.07M | 0.03% | 426 |
|
|
2023
Q3 | $1.68M | Buy |
28,874
+6,909
| +31% | +$401K | 0.02% | 469 |
|
|
2023
Q2 | $1.18M | Sell |
21,965
-30,130
| -58% | -$1.62M | 0.01% | 505 |
|
|
2023
Q1 | $2.07M | Buy |
+52,095
| New | +$2.07M | 0.02% | 495 |
|